Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

HLA high-resolution typing for sensitized patients: a solution in search of a problem?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Quantifying the risk of incompatible kidney transplantation: a multicenter study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

The role of donor-specific HLA alloantibodies in liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Response: Good ethics require good science: why transplant programs should not disclose misattributed parentage.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011

Related Experiment Video

Updated: Jun 6, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Desensitization: achieving immune detente.

A A Zachary1, H S Eng

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aaz@jhmi.edu

Tissue Antigens
|December 16, 2010
PubMed
Summary
This summary is machine-generated.

Desensitization protocols enable successful organ transplantation by reducing donor-specific antibodies. Ongoing monitoring is crucial to manage the increased risk of antibody-mediated rejection in these patients.

More Related Videos

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Nephrology

Background:

  • Donor-specific antibodies (human leukocyte antigen [HLA] and ABO antigens) historically contraindicated organ transplantation.
  • Desensitization protocols have emerged as a viable strategy to overcome antibody barriers.
  • These protocols aim to reduce antibody levels, enabling transplantation in previously ineligible patients.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of desensitization protocols in organ transplantation.
  • To compare different desensitization strategies, including IVIg and plasmapheresis.
  • To assess the long-term risks and management of antibody-mediated rejection (AMR) post-transplantation.

Main Methods:

  • Utilized high-dose intravenous immunoglobulin (IVIg) or plasmapheresis with low-dose IVIg as primary desensitization strategies.
  • Administered standard immunosuppressive agents alongside adjunctive therapies like cell-depleting antibodies.
  • Monitored antibody titers and graft function post-transplantation.

Main Results:

  • Successful transplantation achieved in ABO-incompatible (ABOi) and HLA-positive crossmatch renal transplants.
  • Graft and patient survival rates comparable to non-sensitized recipients.
  • Desensitized patients exhibit a higher incidence of antibody-mediated rejection (AMR).

Conclusions:

  • Desensitization protocols significantly expand the donor pool for organ transplantation.
  • Persistent antibodies post-transplantation increase AMR risk, necessitating continuous monitoring.
  • Desensitization research offers insights into immune dysfunction and regulatory processes.